Ctt Pharmaceutical Holdings, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OQB
CTT Pharmaceutical Holdings, Inc. announced the U.S. Patent Office has granted a continuation-in-part patent for its micelle delivery technology, now covering nicotine, vitamins, and caffeine across various oral dosage forms.